MARKET VIEW FOR 19TH JANUARY 2011

NIFTY MANAGED TO CLIMB ABOVE 5700 ON GOOD NUMBERS FROM TCS AND TECH RALLY ALSO POSITIVE GLOBAL CUES PLAYED GOOD ROLE.

CROSS ABOVE 5750 AND 5800 SEEMS TOUGH IN THIS SERIES. ALSO DOWN WARD SEEMS TO BE LIMITED TO 5600 IN THIS SERIES HENCE SELLING 5900, 6000, 6100 CALLS OF JANUARY SERIES FOR  SMALL AMOUNTS TO EARN SAFELY

ALSO FOR EXPIRY POINT OF VIEW SELLING RELIANCE 1080, 1050 CALLS( JANUARY SERIES) AND RELIANCE 1000 PUTS (JANUARY SERIES)ON EVERY RISE TILL 1030-1040 WILL BE HELPFUL IN EARNING 15-30 RUPEES BY 26TH JANUARY.

ALSO FOR EXPIRY POINT OF VIEW SELLING HUL 340, 320 CALLS( JANUARY SERIES) AND HUL 300 PUTS ( JANUARY SERIES)ON EVERY RISE TILL 310-315 WILL BE HELPFUL IN EARNING 3-5 RUPEES BY 26TH JANUARY.

STOCKS TO WATCH TODAY FOR INTRADAY BOTH LONG & SHORT:

BAJAJ AUTO (1294) ( SEE THE RESULT IMPACT, MAY MOVE UP

SUN PHARMA (484)  MAY MOVE UP TILL 500-505 KEEP SL 465

BAJAJ FIN SERV MAY MOVE TO 490+++

POLARIS MAY MOVE TO 190++++++

HCL TECH, HUL, RELIANCE, ETC

Safe Harbor Statement:

Some forward looking statements on projections, estimates, expectations & outlook are included to enable a better comprehension of the Company prospects. Actual results may, however, differ materially from those stated on account of factors such as changes in government regulations, tax regimes, economic developments within India and the countries within which the Company conducts its business, exchange rate and interest rate movements, impact of competing products and their pricing, product demand and supply constraints.Nothing in this article is, or should be construed as, investment advice.

Disclaimer:

This is neither an offer nor a solicitation to purchase or sell securities. The information and views contained on this blog are believed to be reliable, but no responsibility (or liability) is accepted for errors of fact or opinion. Writers and contributors may be trading in, or have positions in the securities mentioned in their articles. Neither I (Vikas Srivastava) nor any of the contributors accepts any liability arising out of use of the above information/article. Reproduction in whole or in part without written permission is prohibited.